List of Tables
Table 1. Geriatric Medicines Market Trends
Table 2. Geriatric Medicines Market Drivers & Opportunity
Table 3. Geriatric Medicines Market Challenges
Table 4. Geriatric Medicines Market Restraints
Table 5. Global Geriatric Medicines Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Geriatric Medicines Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Geriatric Medicines Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Geriatric Medicines Product Type
Table 9. Key Companies Time to Begin Mass Production of Geriatric Medicines
Table 10. Global Geriatric Medicines Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geriatric Medicines as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Geriatric Medicines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Geriatric Medicines Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Geriatric Medicines Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Geriatric Medicines Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Geriatric Medicines Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Geriatric Medicines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Geriatric Medicines Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Geriatric Medicines Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Geriatric Medicines Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Geriatric Medicines Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Geriatric Medicines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Geriatric Medicines Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Geriatric Medicines Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Geriatric Medicines Sales Value by Region (2019-2024) & (%)
Table 27. Global Geriatric Medicines Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Geriatric Medicines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Geriatric Medicines Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Geriatric Medicines Sales Value, (2025-2030) & (US$ Million)
Table 31. Eli Lilly and Company Basic Information List
Table 32. Eli Lilly and Company Description and Business Overview
Table 33. Eli Lilly and Company Geriatric Medicines Products, Services and Solutions
Table 34. Revenue (US$ Million) in Geriatric Medicines Business of Eli Lilly and Company (2019-2024)
Table 35. Eli Lilly and Company Recent Developments
Table 36. AstraZeneca Basic Information List
Table 37. AstraZeneca Description and Business Overview
Table 38. AstraZeneca Geriatric Medicines Products, Services and Solutions
Table 39. Revenue (US$ Million) in Geriatric Medicines Business of AstraZeneca (2019-2024)
Table 40. AstraZeneca Recent Developments
Table 41. Boehringer Ingelheim Basic Information List
Table 42. Boehringer Ingelheim Description and Business Overview
Table 43. Boehringer Ingelheim Geriatric Medicines Products, Services and Solutions
Table 44. Revenue (US$ Million) in Geriatric Medicines Business of Boehringer Ingelheim (2019-2024)
Table 45. Boehringer Ingelheim Recent Developments
Table 46. Abbott Laboratories Basic Information List
Table 47. Abbott Laboratories Description and Business Overview
Table 48. Abbott Laboratories Geriatric Medicines Products, Services and Solutions
Table 49. Revenue (US$ Million) in Geriatric Medicines Business of Abbott Laboratories (2019-2024)
Table 50. Abbott Laboratories Recent Developments
Table 51. Sanofi Basic Information List
Table 52. Sanofi Description and Business Overview
Table 53. Sanofi Geriatric Medicines Products, Services and Solutions
Table 54. Revenue (US$ Million) in Geriatric Medicines Business of Sanofi (2019-2024)
Table 55. Sanofi Recent Developments
Table 56. Bristol-Myers Squibb Basic Information List
Table 57. Bristol-Myers Squibb Description and Business Overview
Table 58. Bristol-Myers Squibb Geriatric Medicines Products, Services and Solutions
Table 59. Revenue (US$ Million) in Geriatric Medicines Business of Bristol-Myers Squibb (2019-2024)
Table 60. Bristol-Myers Squibb Recent Developments
Table 61. Merck Basic Information List
Table 62. Merck Description and Business Overview
Table 63. Merck Geriatric Medicines Products, Services and Solutions
Table 64. Revenue (US$ Million) in Geriatric Medicines Business of Merck (2019-2024)
Table 65. Merck Recent Developments
Table 66. Novartis Basic Information List
Table 67. Novartis Description and Business Overview
Table 68. Novartis Geriatric Medicines Products, Services and Solutions
Table 69. Revenue (US$ Million) in Geriatric Medicines Business of Novartis (2019-2024)
Table 70. Novartis Recent Developments
Table 71. Pfizer Basic Information List
Table 72. Pfizer Description and Business Overview
Table 73. Pfizer Geriatric Medicines Products, Services and Solutions
Table 74. Revenue (US$ Million) in Geriatric Medicines Business of Pfizer (2019-2024)
Table 75. Pfizer Recent Developments
Table 76. GSK Basic Information List
Table 77. GSK Description and Business Overview
Table 78. GSK Geriatric Medicines Products, Services and Solutions
Table 79. Revenue (US$ Million) in Geriatric Medicines Business of GSK (2019-2024)
Table 80. GSK Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Geriatric Medicines Downstream Customers
Table 84. Geriatric Medicines Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Geriatric Medicines Product Picture
Figure 2. Global Geriatric Medicines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Geriatric Medicines Sales Value (2019-2030) & (US$ Million)
Figure 4. Geriatric Medicines Report Years Considered
Figure 5. Global Geriatric Medicines Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Geriatric Medicines Revenue in 2023
Figure 7. Geriatric Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Analgesics Picture
Figure 9. Antihypertensives Picture
Figure 10. Statins Picture
Figure 11. Antidiabetics Picture
Figure 12. Proton Pump Inhibitor Picture
Figure 13. Anticoagulant Picture
Figure 14. Antipsychotics Picture
Figure 15. Antidepressants Picture
Figure 16. Global Geriatric Medicines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Geriatric Medicines Sales Value Market Share by Type, 2023 & 2030
Figure 18. Product Picture of Cardiovascular diseases
Figure 19. Product Picture of Arthritis
Figure 20. Product Picture of Neurological Disorders
Figure 21. Product Picture of Cancer
Figure 22. Product Picture of Osteoporosis
Figure 23. Product Picture of Respiratory
Figure 24. Product Picture of Other
Figure 25. Global Geriatric Medicines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global Geriatric Medicines Sales Value Market Share by Application, 2023 & 2030
Figure 27. North America Geriatric Medicines Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Geriatric Medicines Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Geriatric Medicines Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Geriatric Medicines Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Geriatric Medicines Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Geriatric Medicines Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Geriatric Medicines Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Geriatric Medicines Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Geriatric Medicines Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Geriatric Medicines Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Geriatric Medicines Sales Value (%), (2019-2030)
Figure 38. United States Geriatric Medicines Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Geriatric Medicines Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Geriatric Medicines Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Geriatric Medicines Sales Value by Application (%), 2023 VS 2030
Figure 44. China Geriatric Medicines Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
Figure 46. China Geriatric Medicines Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Geriatric Medicines Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Geriatric Medicines Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Geriatric Medicines Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Geriatric Medicines Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Geriatric Medicines Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Geriatric Medicines Sales Value by Application (%), 2023 VS 2030
Figure 56. India Geriatric Medicines Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
Figure 58. India Geriatric Medicines Sales Value by Application (%), 2023 VS 2030
Figure 59. Geriatric Medicines Industrial Chain
Figure 60. Geriatric Medicines Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
